2,3,4,7,8-pentabromodibenzofuran

Suppliers

Names

[ CAS No. ]:
131166-92-2

[ Name ]:
2,3,4,7,8-pentabromodibenzofuran

[Synonym ]:
Dibenzofuran,2,3,4,7,8-pentabromo
2,3,4,7,8-pentabromo-dibenzofuran

Chemical & Physical Properties

[ Density]:
2.541g/cm3

[ Boiling Point ]:
537.5ºC at 760mmHg

[ Molecular Formula ]:
C12H3Br5O

[ Molecular Weight ]:
562.67200

[ Flash Point ]:
278.9ºC

[ Exact Mass ]:
557.61000

[ PSA ]:
13.14000

[ LogP ]:
7.39850

[ Vapour Pressure ]:
4.4E-11mmHg at 25°C

[ Index of Refraction ]:
1.777

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
HP5295130
CHEMICAL NAME :
Dibenzofuran, 2,3,4,7,8-pentabromo-
CAS REGISTRY NUMBER :
131166-92-2
LAST UPDATED :
199110
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C12-H3-Br5-O
MOLECULAR WEIGHT :
562.70

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
7200 ug/kg
SEX/DURATION :
female 10-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - urogenital system
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 107,141,1991
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
21600 ug/kg
SEX/DURATION :
female 10-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - urogenital system
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 107,141,1991

Related Compounds

  • 2,3,4,7,8,9-hexahydropyrano[3,2-h][1]benzoxepin-6-one
  • 2,3,4,7,8,8a-Hexahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulene-5-methanol
  • 2,3,4,7,8,9,10,11,12,13,14,15,16,17-Tetradecahydro-10,13-dimethyl-1H-cyclopenta[a]phenanthren-3-ol
  • 2,3,4,7,8,9-hexahydro-1H-benzo[7]annulen-9-yl(dimethyl)azanium,chloride
  • 2,3,4,7,8,9-hexahydrooxecin-10-one
  • 1,2,3,4,7,8-hexachlorodibenzofuran
  • tert-butyl N-(3-methoxy-2-sulfamoylphenyl)carbamate
  • tert-butyl N-{[(2S,4S)-4-fluoro-1-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]pyrrolidin-2-yl]methyl}-N-methylcarbamate
  • tert-butyl N-{[(2S,4S)-4-fluoro-1-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]pyrrolidin-2-yl]methyl}carbamate
  • tert-butyl N-{[(2S,4S)-4-fluoro-1-[(5-methyl-1,2-oxazol-4-yl)methyl]pyrrolidin-2-yl]methyl}carbamate
  • 2-[4-(2,2,2-Trifluoroacetyl)piperazin-1-yl]pentanoic acid
  • 3-{Methyl[1-(2,2,2-trifluoroacetyl)piperidin-4-yl]amino}propanoic acid
  • 3-[3-Methyl-5-(trifluoroacetamido)piperidin-1-yl]propanoic acid
  • rac-(3'aR,6'aR)-1-[(prop-2-en-1-yloxy)carbonyl]-hexahydrospiro[azetidine-3,1'-furo[3,4-c]pyrrole]-3'a-carboxylic acid
  • 3-Oxo-1-[(prop-2-en-1-yloxy)carbonyl]-decahydroquinoxaline-6-carboxylic acid
  • tert-butyl N-(2-ethoxy-5-nitrophenyl)carbamate
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.